| A5 | Robust anti-viral immune responses at the placenta during early gestation limit in utero HIV infection and replication | E-poster | Innate immunity |
| A6 | Isolation of SIVmac239 neutralizing antibodies with different specificities from infected rhesus macaques | E-poster | Humoral immunity (including broadly neutralizing antibodies) |
| A6 | Immunogenicity of a 2-dose human papillomavirus vaccination schedule in HIV-infected adolescents with immune reconstitution | E-poster | Humoral immunity (including broadly neutralizing antibodies) |
| A6 | Neutralizing antibody induction associated with a germline immunoglobulin gene polymorphism in rhesus macaques after neutralization-resistant SIVsmE543-3 infection | E-poster | Humoral immunity (including broadly neutralizing antibodies) |
| A7 | Daily immunological and virological variations in aviremic ART-treated people living with HIV | E-poster | Cellular immunity |
| A7 | Impact of age on T cell exhaustion in children, adolescents and adults with vertically acquired HIV infection | E-poster | Cellular immunity |
| A7 | Cross-reactivity to mutated viral immune targets can influence CD8+ T cell functionality: an alternative viral adaptation strategy | E-poster | Cellular immunity |
| A8 | Retinoic acid boosts HIV-1 replication in monocyte-derived macrophages | E-poster | Mucosal immunity |
| A9 | Changes in inflammation scores among people living with HIV (PLWH) under different antiretroviral treatment (ART) regimes | E-poster | Systemic immune activation and inflammation |
| A9 | Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy | E-poster | Systemic immune activation and inflammation |